[Edaily Reporter Kwon Oh Seok ] HYULIM A-TECH(078590)’s stock price surged to the daily upper limit early in the trading session. It appears that buying interest is surging following news that the company is accelerating the acquisition of AIDIOS CO., LTD.—which possesses artificial intelligence (AI) and specialized equipment technologies—and is set to make a full-scale entry into the AI defense and public safety robotics market. According to MP Doctor on the 23rd, as of 9:18 a.m., HYULIM A-TECH is trading at 3,365 won—the daily price limit—up 29.92% from the previous trading day. Earlier that day, the company issued a press release stating, “At a recent extraordinary general meeting of shareholders, we completed an amendment to the articles of incorporation to add DIO Corporation’s core robotics businesses—including the manufacture of military robot components, landmine detection and removal, and explosive ordnance disposal (EOD) robots—as new business objectives.” In line with the completion of its acquisition of a stake in IDOS (51% or more), the company has laid the institutional groundwork to immediately enter the AI defense robotics market. Established in 2021, IDOS is a technology-intensive, small-to-medium-sized AI robotics company that has been independently developing and manufacturing core defense and security equipment ranging from explosive detection to disposal. Through this acquisition, HYULIM A-TECH plans to completely transform its business model from a simple manufacturing company into a specialist in “AI-based integrated solutions for unmanned intelligent defense and counter-terrorism robots,” thereby driving a re-rating of its value in the physical AI and specialty robotics markets, which have recently been gaining significant attention.
Venture capital (VC) firms have begun taking a direct role in talent recruitment for their portfolio companies. Some have partnered with universities to host job fairs that bring their portfolio compa…
The United Arab Emirates (UAE) is demonstrating its interest in South Korea’s cutting-edge regenerative biotechnology—including cell and gene therapy (CGT)—through concrete actions. As a result of the…
(Graphic: ChatGPT)
A domestically developed treatment with a new mechanism of action is set to enter the Korean dry eye market, which has long been dominated by artificial tears. This follows the …